Catalogue Number: 27102-IBL
|Manufacturer:||IBL - (Immuno-Biologicals Laboratories Co Ltd)|
|Type:||Mouse ELISA Kit|
|Shipping Condition:||Blue Ice|
|Range:||62.5 ～ 4,000 pg/mL|
|Sample type:||EDTA-plasma, Serum, Cell culture supernatant|
Description: Vascular Endothelial Cell Growth Factor (VEGF) is a homodimeric protein initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and secreted by a variety of vascularized tissues. It was subsequently found to be identical to a vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based upon its ability to increase the permeability of capillary blood vessels. The reported activities of VEGF include stimulation of endothelial cell growth, angiogenesis and capillary permeability. Human VEGF is a 38.2kDa homodimeric protein consisting of two 165 amino acid polypeptide chains. VEGF is expressed in many human tumor cells, including human adenocarcinoma, human pancreatic carcinoma, human hepatocellular carcinoma, renal cell carcinoma, fibrosarcoma, HL60 promyelocytic leukemia, GS-9L glioma and U937 lymphoma cells. In normal tissues, VEGF expression has been observed in activated macrophages, keratinocytes, hepatocytes, smooth muscle cells Leydig cells, embryonic fibroblasts and bronchial and choroids plexus epithelium, renal glomerular visceral epithelium and mesangial cells. In contrast to VEGF, VEGF-C, which was discovered as a VEGF-associated molecule, has been identified as a molecule that stimulates lymph vessel formation through VEGFR-3, its specific lymphatic endothelium receptor. The existence of human VEGF-C molecules having different molecular weights as a result of proteolytic processing has been reported. The kit is a complete kit for the quantitative determination of mouse VEGF.
Compound Cross Reactivity Mouse VEGF 164 100.0% Human VEGF 165 ≤0.1 %